Skip to content
S3005Senate2023-2024 SessionSame asA6450

Expand Prescription Coverage Panel

Official title

“Relates to establishing the expanded pharmaceutical insurance coverage panel”

Sponsor Cordell CleareSD-30Affects Finance
Status
In Senate Committee
Finance
Impact
6/10
Moderate
Passage
0%

Bill progress

Step 2 of 7

In committee · Finance

What's happening

This bill creates an expanded pharmaceutical insurance coverage panel to oversee and improve New York's prescription drug coverage for eligible residents.

Why it matters

  1. Creates a multi-agency panel with broad oversight. By bringing together top officials from education, health, financial services, aging, and budget, the panel ensures that pharmaceutical insurance coverage decisions consider diverse expertise and the varied needs of New Yorkers.

  2. Gives the panel direct influence over program design and costs. The panel will set annual cost-sharing rules, manage contracts, and have the authority to recommend and implement program improvements, potentially increasing efficiency and responsiveness to changing healthcare needs.

  3. Focuses on outreach and transparency. The panel is required to develop outreach programs to inform eligible residents, especially seniors, about available benefits and must publish detailed annual reports on enrollment, spending, and cost-containment efforts—helping to ensure accountability and continuous improvement.

  4. Incorporates consumer voices. An advisory committee with at least 60% consumer representation will provide input to the panel, aiming to keep the program attuned to real-world needs and the experiences of patients, pharmacists, and other stakeholders.

The daily · weekday mornings

Albany, before your first meeting.

Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.

Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.

Who cares

  • Eligible prescription coverage participants and applicants

    The panel would set annual participant cost-sharing schedules and coordinate outreach about available state and federally funded prescription drug benefits.

  • State health, aging, education, financial services and budget officials

    They would serve on the panel, which would oversee regulations, contracts, program improvements and annual reporting.

  • Consumer advocates

    Consumer representatives would hold at least 60 percent of the seats on a twelve-member advisory committee that would advise the panel on program improvements.

  • Pharmacists, drug manufacturers and pharmaceutical wholesalers

    Their representatives would serve on the advisory committee, giving them a role in advising on program improvements.

Headline styles

Expand Prescription Coverage Panel

Plain English, a few words. Used as the page title.

Sponsors

Primary sponsor
Cordell Cleare

Senator · Senate District 30

Chair, Aging

No co-sponsors yet.

History

  1. Print number 3005b
  2. Amend (t) and recommit to finance
  3. Reported and committed to finance
  4. Print number 3005a
  5. Amend and recommit to aging
  6. Referred to aging
  7. Reported and committed to health
  8. Referred to aging

Companion bill

The same bill in the other chamber. A bill becomes law when one version passes both houses and the governor signs it, so either number can carry it.

A6450Assembly

Create Drug Coverage Panel

In Assembly Committee · Aging · Sponsor Ron Kim

Impact 6 · Moderate0% to pass

Full text

2 pagesUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗

STATE OF NEW YORK

3005--B

2023-2024 Regular Sessions

IN SENATE

January 26, 2023

Introduced by Sen. CLEARE -- read twice and ordered printed, and when printed to be committed to the Committee on Aging -- recommitted to the Committee on Aging in accordance with Senate Rule 6, sec. 8 -committee discharged, bill amended, ordered reprinted as amended and recommitted to said committee -- reported favorably from said committee and committed to the Committee on Finance -- committee discharged, bill amended, ordered reprinted as amended and recommitted to said committee

AN ACT to amend the elder law, in relation to establishing the expanded pharmaceutical insurance coverage panel

The People of the State of New York, represented in Senate and Assembly, do enact as follows:

Section 1. The elder law is amended by adding a new section 242-a to read as follows:

§ 242-a. Expanded pharmaceutical insurance coverage panel. 1. There is hereby established within the executive department, a panel to be known as the "expanded pharmaceutical insurance coverage panel". For the purposes of this section, the term "the panel" shall mean the expanded pharmaceutical insurance coverage panel.

2. The panel shall consist of the commissioners of the departments of education and health, the superintendent of the department of financial services, and the directors of the office for the aging and the division of the budget. Each panel member may designate an officer of their respective department, office, or division to represent and exercise all the powers of such panel member at any meeting of the panel from which such panel member may be absent.

3. The director of the office for the aging and the commissioner of health shall serve as co-chairs of the panel.

4. The panel shall meet at such times as may be requested by the co-chairs, provided that the panel shall meet at least two times a year.

5. The panel shall:

EXPLANATION--Matter in italics (underscored) is new; matter in brackets

[ ] is old law to be omitted.

LBD01416-04-4

(a) subject to the approval of the director of the budget, promulgate program regulations pursuant to section two hundred forty-six of this title;

(b) determine the annual schedule of cost-sharing responsibilities of eligible program participants pursuant to sections two hundred fortyseven and two hundred forty-eight of this title;

(c) enter into contracts pursuant to section two hundred forty-three of this title;

(d) recommend and implement alternative program improvements for the efficient and effective operation of the program in accordance with the provisions of this title with the advice of the advisory committee as defined in subdivision seven of this section;

(e) develop and implement, in cooperation with area offices for the aging, an outreach program to inform eligible applicants of benefits they may be entitled to pursuant to this title, and to make available information concerning the program for expanded pharmaceutical insurance coverage and benefits to which they may be entitled through a prescription drug coverage program funded by the federal government; and

(f) prepare an annual report and submit such report to the governor, the temporary president of the senate, and the speaker of the assembly no later than the first day of January of each year. The panel shall include in such report, at a minimum, annual statistical information regarding the number of persons enrolled in the program by marital status and income level and age, an estimate of the per cent of eligible New York residents that are enrolled, the total number of enrollees that receive an income-related subsidy under section 1860D-14 of the federal social security act, and the number that so qualify through their enrollment in the medicare savings program, the numbers of participating provider pharmacies, recipients and payments by county, a summary of the administrative cost containment initiatives completed during the year, projections of program costs for the following two years, and an evaluation of the performance of the program contractor or contractors and of the cost effectiveness of all outreach efforts.

6. The panel members shall receive no compensation for their services as panel members.

7. There shall be an advisory committee to the panel comprised of twelve persons. Four members shall be appointed by the governor, three members shall be appointed by the temporary president of the senate, one member shall be appointed by the minority leader of the senate, three members shall be appointed by the speaker of the assembly and one member shall be appointed by the minority leader of the assembly. The committee members shall be representatives of consumers, pharmacists, pharmaceutical drug manufacturers and pharmaceutical wholesalers. No less than sixty percent of the committee membership shall represent consumers. Committee members shall receive no compensation for their services but shall be allowed their actual and necessary expenses incurred in the performance of their duties.

§ 2. This act shall take effect immediately.

Reflowed for reading: line numbers and page breaks removed. Cite the official text.

Sponsor's memo

Title of bill

An act to amend the elder law, in relation to establishing the expanded pharmaceutical insurance coverage panel

Purpose

This bill will establish the expanded pharmaceutical insurance coverage panel to restore oversight and transparency to the function of the program and allow for future decisions to be made in an accountable fashion.

Summary of specific provisions

This Bill Restores the EPIC panel and the advisory committee, 60% of the later being composed of consumers, and requires an annual report.

Justification

THE EPIC program has made numerous changes administratively that have negatively impacted enrollees without a public process to review proposed changes. These changes include: òa change in the application starting in 2020, that* requires enrollees to determine if they must disclose asset, not otherwise a program requirement, if they fall into the income category that would allow them to apply for the federal Low Income Subsidy (LIS.) In prior years, an EPIC applicant was enrolled in without an asset test and if the EPIC staff found that the self-reported income could qualify for LIS (150% FPL,) the enrollee would be contacted for additional information on assets so that an application to LIS was completed on behalf of the enrollee. Additionally, while the current statute includes a role for'EPIC staff to assist enrollees who are eligible for the Medicare Savings Program (MSP, 135% FPL,) which without an asset test, will also qualify an enrollee for LIS, the EPIC program does not assist with MSP enrollment or make a referral to an agency that will.

* a change implemented in October 2019 that eliminated the previous benefit to include payment of any Medicare Part D late enrollment penal- ty for certain enrollees.

* a change in January 2020 that eliminates past records of EPIC partic- ipation for any enrollee that failed to pay their quarterly dues on time. Their EPIC number and all income information on their records is now eradicated, and upon late payment of the dues an enrollee must reap- ply for the program as if they were never a member. In addition to making corrections to restore and improve program operations, the chang- es noted above are addressed in this bill. Further, in order to improve transparency and accountability, the EPIC panel and advisory committee are re-convened, along with a requirement for an annual report to the Legislature.

Fiscal implications

To be determined, but has been made difficult without publicly available annual reports on the program. In part, costs associated with prograth

expansion to a lower age limit will be offset by rejecting the proposed program savings of $16.5m proposed for SFY 2020-21.

Effective date

This act shall take effect immediately.

Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.